Suven Life gets patents for molecules in three countries

Written By Unknown on Selasa, 24 Maret 2015 | 21.03

These patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts, Suven said.

Drug firm Suven Life Sciences  has been granted patents each by Canada, Japan and Korea for molecules, aimed to be developed as drugs, for the treatment of neuro-degenerative diseases.

The patents are valid through 2030, Suven Life Sciences said in a filing to the BSE. Commenting on the development, Suven Life CEO Venkat Jasti said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally."

The granted patents include the class of selective 5-HT compounds discovered by the company and are being developed as therapeutic agents useful in the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's disease, Huntington's disease, Parkinson and Schizophrenia, among others, Suven said.

"With these new patents, Suven has a total of eighteen granted patents from Canada, sixteen granted patents from Japan and sixteen product patents from Korea," it added.

These patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts, Suven said. "Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II," it added.

Suven Life Sciences shares were trading 5.15 percent up at Rs 293.95 per scrip during afternoon trade on the BSE.

Suven Life Sci stock price

On March 24, 2015, Suven Life Sciences closed at Rs 297.40, up Rs 17.85, or 6.39 percent. The 52-week high of the share was Rs 322.90 and the 52-week low was Rs 73.20.


The company's trailing 12-month (TTM) EPS was at Rs 9.76 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 30.47. The latest book value of the company is Rs 20.86 per share. At current value, the price-to-book value of the company is 14.26.


Anda sedang membaca artikel tentang

Suven Life gets patents for molecules in three countries

Dengan url

http://kebugaranhidup.blogspot.com/2015/03/suven-life-gets-patents-for-molecules.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Suven Life gets patents for molecules in three countries

namun jangan lupa untuk meletakkan link

Suven Life gets patents for molecules in three countries

sebagai sumbernya

0 komentar:

Posting Komentar

techieblogger.com Techie Blogger Techie Blogger